Ajanta Pharma Limited

AJANTPHARM

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 20261,725

    Quarter₹ croreYoY
    Sept 20241,129+19.4%
    Dec 20241,102+1.5%
    Mar 20251,014+9.5%
    Jun 20251,209+12.2%
    Sept 20251,220+8.1%
    Dec 20251,207+9.5%
    Mar 20261,211+19.4%
    Jun 20261,489+23.2%
    Sept 20261,725+41.4%
  • ₹ crore

    Sept 202653

    Quarter₹ crore
    Sept 202440
    Dec 202433
    Mar 202518
    Jun 202541
    Sept 202575
    Dec 202526
    Mar 202663
    Jun 202671
    Sept 202653
  • ₹ crore

    Sept 20261,778

    Quarter₹ crore
    Sept 20241,169
    Dec 20241,135
    Mar 20251,032
    Jun 20251,249
    Sept 20251,295
    Dec 20251,232
    Mar 20261,274
    Jun 20261,559
    Sept 20261,778
  • Cost structure
  • ₹ crore

    Sept 2026355

    Quarter₹ crore
    Sept 2024242
    Dec 2024246
    Mar 2025258
    Jun 2025281
    Sept 2025293
    Dec 2025306
    Mar 2026313
    Jun 2026353
    Sept 2026355
  • ₹ crore

    Sept 20261,255

    Quarter₹ crore
    Sept 2024860
    Dec 2024803
    Mar 2025804
    Jun 2025920
    Sept 2025973
    Dec 2025910
    Mar 20261,016
    Jun 20261,136
    Sept 20261,255
  • Exceptional items and tax
  • ₹ crore

    Sept 2026523

    Quarter₹ crore
    Sept 2024309
    Dec 2024332
    Mar 2025228
    Jun 2025329
    Sept 2025322
    Dec 2025322
    Mar 2026258
    Jun 2026423
    Sept 2026523
  • ₹ crore

    Sept 2026143

    Quarter₹ crore
    Sept 202474
    Dec 202480
    Mar 202535
    Jun 202574
    Sept 202572
    Dec 202577
    Mar 202660
    Jun 2026108
    Sept 2026143
  • Profit
  • ₹ crore

    Sept 2026380

    Quarter₹ croreYoY
    Sept 2024235+10.7%
    Dec 2024252+14.7%
    Mar 2025193+18.9%
    Jun 2025255+8.0%
    Sept 2025250+6.2%
    Dec 2025245-2.9%
    Mar 2026197+2.0%
    Jun 2026315+23.7%
    Sept 2026380+52.2%
  • Per share
  • ₹ per share

    Sept 202630.40

    Quarter₹ per share
    Sept 202418.75
    Dec 202420.16
    Mar 202515.46
    Jun 202520.41
    Sept 202519.98
    Dec 202519.61
    Mar 202615.79
    Jun 202625.25
    Sept 202630.40
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
1,1291,1021,0141,2091,2201,2071,2111,4891,725
Revenue YoY+19.4%+1.5%+9.5%+12.2%+8.1%+9.5%+19.4%+23.2%+41.4%
403318417526637153
1,1691,1351,0321,2491,2951,2321,2741,5591,778
Cost structure
242246258281293306313353355
8608038049209739101,0161,1361,255
Exceptional items and tax
309332228329322322258423523
74803574727760108143
Profit
235252193255250245197315380
Net profit YoY+10.7%+14.7%+18.9%+8.0%+6.2%-2.9%+2.0%+23.7%+52.2%
Per share
18.7520.1615.4620.4119.9819.6115.7925.2530.40

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.